Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Efren Barragan Avila

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Cancer|February 5, 2022
Lethal lipotoxicity for liver cancer therapySuchira Gallage, Jose Efren Barragan Avila, Mathias Heikenwalder
Cellular and Molecular Gastroenterology and Hepatology|February 15, 2022
ReplySuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Nature Metabolism|December 20, 2022
A researcher's guide to preclinical mouse NASH modelsSuchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 9, 2021
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASHSuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Nature Communications|February 3, 2024
Detection of senescence using machine learning algorithms based on nuclear featuresImanol Duran, Joaquim Pombo, Bin Sun, et al.
Nature Aging|August 29, 2024
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretomeSuchira Gallage, Elaine E Irvine, Jose Efren Barragan Avila, et al.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Immunity|June 17, 2023
Sublethal necroptosis signaling promotes inflammation and liver cancerMihael Vucur, Ahmed Ghallab, Anne T Schneider, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Cancer|February 5, 2022
Lethal lipotoxicity for liver cancer therapySuchira Gallage, Jose Efren Barragan Avila, Mathias Heikenwalder
Cellular and Molecular Gastroenterology and Hepatology|February 15, 2022
ReplySuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Nature Metabolism|December 20, 2022
A researcher's guide to preclinical mouse NASH modelsSuchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 9, 2021
Spontaneous Cholemia in C57BL/6 Mice Predisposes to Liver Cancer in NASHSuchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Nature Communications|February 3, 2024
Detection of senescence using machine learning algorithms based on nuclear featuresImanol Duran, Joaquim Pombo, Bin Sun, et al.
Nature Aging|August 29, 2024
Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretomeSuchira Gallage, Elaine E Irvine, Jose Efren Barragan Avila, et al.
Cell Metabolism|May 8, 2024
A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, et al.
Immunity|June 17, 2023
Sublethal necroptosis signaling promotes inflammation and liver cancerMihael Vucur, Ahmed Ghallab, Anne T Schneider, et al.
Pageof 1